Loading Events

The Search For Drugs That Slow Ageing – Are We There Yet? and Why Not?: Prof. Richard A. Miller

  • This event has passed.

Open to: Academic | Alumni | Public | Student
Admission: Free
Ticketing: Pre-booking essential

Nearly everyone who does medical research works on one disease at a time: cancer, or AIDS, or Alzheimer’s, or what have you. One problem with this approach is that even dramatic success would do surprisingly little to improve human health: a complete cure for human cancer, for example, would extend average human lifespan by about 2.6 years, i.e. only about 3%. In contrast, biogerontologists have shown, over the last two decades, that fiddling with the basic mechanisms of aging can increase the lifespan of mice by up to 40%, i.e. about 10-fold the change you’d expect from a cancer cure in people. The healthy lifespan of mice can be increased dramatically by at least half a dozen genetic mutations, by at least two forms of dietary intervention, and more recently by at least two drugs. These discoveries refute the assumption, commonly held by most scientists and the lay public alike, that aging cannot be slowed.

Richard A. Miller, Professor of Pathology, University of Michigan Medical School, Richard Miller is a Professor of Pathology, University of Michigan Medical School Associate Director for Research, Geriatrics Center, University of Michigan Director, Nathan Shock Center in the Biology of Aging, University of Michigan


December 5, 2013
6:00 pm - 7:30 pm


4th Floor Seminar Room | Wellcome Trust Centre for Neuroimaging
12 Queen Square, London, Select a State: WC1N 3BG United Kingdom
+ Google Map


UCL School of Life and Medical Sciences
+44 (0)20 7679 8585

Cookies on IBME website

Our website uses cookies to provide us with important information about visitors. By continuing to browse the site we'll assume that you are happy to receive all cookies set by IBME.